Public Profile

Lonza Inc.

Lonza Inc., a prominent player in the life sciences and biotechnology sectors, is headquartered in the United States. Founded in 1897, the company has evolved significantly, establishing itself as a leader in custom manufacturing and development services for pharmaceuticals, biologics, and specialty ingredients. With major operational regions across Europe, Asia, and North America, Lonza is well-positioned to serve a global clientele. The company offers a diverse range of core products and services, including cell and gene therapies, microbial and mammalian cell culture, and advanced drug delivery systems. Lonza's commitment to innovation and quality has earned it a strong market position, recognised for its cutting-edge technologies and sustainable practices. Notable achievements include strategic partnerships and expansions that enhance its capabilities in the rapidly evolving life sciences landscape.

DitchCarbon Score

How does Lonza Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

30

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Lonza Inc.'s score of 30 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

54%

Let us know if this data was useful to you

Lonza Inc.'s reported carbon emissions

Lonza Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess the company's climate impact or its strategies for addressing carbon emissions. In the absence of detailed information, it is important to note that many companies in the industry are increasingly focusing on sustainability and setting ambitious climate goals. Lonza's approach to climate commitments remains unclear, highlighting a potential area for further transparency and engagement in environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Lonza Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Lonza Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Lonza Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Aldevron, LLC

US
Research and development services (73)
Updated 4 months ago

Maravai LifeSciences

US
Research and development services (73)
Updated 12 days ago

Samsung Biologics

KR
Research and development services (73)
Updated 22 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers